Epilepsy and sarcopenia: shared neurometabolic mechanisms and emerging brain–muscle interactions
Year: 2026
Type: article
Abstract: Background Emerging evidence suggests that people with epilepsy (PWE) may be at increased risk of impaired muscle health and sarcopenia. However, the mechanisms underlying this association remain uncertain and have not been comprehensively synthesized. Methods A narrative review of clinical and preclinical literature was conducted using PubMed, Scopus, and Web of Science through March 2026. Studies addressing sarcopenia, muscle strength, physical performance, inflammation, mitochondrial dysfunction, neurotrophic signaling, nutrition, physical activity, and anti-seizure medication effects in epilepsy were evaluated. Discussion Clinical studies indicate that PWE frequently exhibit reduced handgrip strength, impaired mobility and balance performance, greater frailty, and a higher prevalence of sarcopenia than controls. Reduced physical activity and mobility limitations are among the better-supported proposed contributors, although their causal contribution to sarcopenia in PWE remains unproven. Preclinical studies and evidence derived from parallel epilepsy and sarcopenia literature further suggest potential roles for chronic inflammation, oxidative stress, mitochondrial dysfunction, altered brain-derived neurotrophic factor (BDNF) signaling, insulin resistance, nutritional deficiencies, and anti-seizure medication-related metabolic effects. However, direct evidence linking these mechanisms to muscle loss in PWE remains limited. Conclusion Current evidence supports an association between epilepsy and impaired muscle health, with physical inactivity, mobility limitations, and antiseizure medication-related effects representing the most consistently supported contributors. Several biological pathways, including inflammation, mitochondrial dysfunction, and altered neurotrophic signaling, remain plausible but incompletely validated mechanisms that require further investigation.
Source: Frontiers in Aging Neuroscience
Institutions: Ajman University, University of Sharjah
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funder: Ajman University
OpenAlex ID: W7235680135
